Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE)

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 12, 2024

Primary Completion Date

September 10, 2026

Study Completion Date

March 12, 2027

Conditions
Solid Tumor
Interventions
OTHER

Off-label or non-standard systemic therapies

Off-label systemic treatments and/or relevant clinical trials recommended by the NCCS Molecular Tumour Board (MTB).

Trial Locations (1)

168583

RECRUITING

National Cancer Centre, Singapore, Singapore

All Listed Sponsors
collaborator

SingHealth Duke-NUS Academic Medical Centre

UNKNOWN

lead

National Cancer Centre, Singapore

OTHER